menu
    • menu

    Company profile for Sumitomo Pharma

    NEW Drugs in Dev: 22
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Sumitomo Pharma, we are focusing our efforts on the research and development of innovative and useful pharmaceuticals as well as healthcare solutions, in the relentless pursuit of our mission: To broadly contribute to society through value creation based on innovative research and development activities for the betterment of healthcare and fuller lives of people worldwide.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sumitomo Pharmajapan Flag
    Country
    Country
    Japan
    Address
    Address
    6-8, Doshomachi 2-chome, Chuo-ku, Osaka, Osaka 541-0045
    Telephone
    Telephone
    +81 662035321
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sumitomo-pharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    EU Grant Orphan Status to Sumitomo's Nuvisertib for Myelofibrosis
    EU Grant Orphan Status to Sumitomo's Nuvisertib for Myelofibrosis

    30 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sumitomo-pharma-america-announces-that-the-european-medicines-agency-has-granted-orphan-drug-designation-to-nuvisertib-tp-3654-for-the-treatment-of-myelofibrosis-302517571.html

    PR NEWSWIRE
    30 Jul 2025
    Share Share
    Sumitomo, Rodney Peete Promote GEMTESA for Overactive Bladder
    Sumitomo, Rodney Peete Promote GEMTESA for Overactive Bladder

    30 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sumitomo-pharma-america-and-former-professional-quarterback-rodney-peete-say-its-time-to-go-and-put-yourself-first-with-overactive-bladder-treatment-option-gemtesa-302494429.html

    PR NEWSWIRE
    30 Jun 2025
    Share Share
    Sumitomo Pharma America: Nuvisertib (TP-3654) Gets FDA Fast Track
    Sumitomo Pharma America: Nuvisertib (TP-3654) Gets FDA Fast Track

    12 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sumitomo-pharma-america-announces-that-nuvisertib-tp-3654-has-received-fda-fast-track-designation-for-the-treatment-of-myelofibrosis-302480390.html

    PR NEWSWIRE
    12 Jun 2025
    Share Share
    Sumitomo, NCI Partner to Advance Enzomenib Cancer Study
    Sumitomo, NCI Partner to Advance Enzomenib Cancer Study

    14 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sumitomo-pharma-america-enters-into-a-cooperative-research-and-development-agreement-with-the-national-cancer-institute-to-advance-clinical-understanding-of-enzomenib-302426994.html

    PR NEWSWIRE
    14 Apr 2025
    Share Share
    Poxel's Partner Sumitomo Reports TWYMEEG Q4 And FY 2024 Sales
    Poxel's Partner Sumitomo Reports TWYMEEG Q4 And FY 2024 Sales

    30 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250130250337/en

    BUSINESSWIRE
    30 Jan 2025
    Share Share
    Poxel To Receive Higher Royalties From Sumitomo For Twymeeg
    Poxel To Receive Higher Royalties From Sumitomo For Twymeeg

    20 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250119375255/en

    BUSINESSWIRE
    20 Jan 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Sumitomo Dainippon Pharma Co., Ltd and get a quotation

    Sumitomo Dainippon Pharma Co., Ltd is a supplier offers 16 products (APIs, Excipients or Intermediates).

    Find Lurasidone Hydrochloride bulk with DMF offered by Sumitomo Dainippon Pharma Co., Ltd

    Find Zonisamide bulk with DMF offered by Sumitomo Dainippon Pharma Co., Ltd

    Find Amrubicin bulk offered by Sumitomo Dainippon Pharma Co., Ltd

    Find Droxidopa bulk offered by Sumitomo Dainippon Pharma Co., Ltd

    Find Enoxacin bulk offered by Sumitomo Dainippon Pharma Co., Ltd

    Find Meropenem bulk offered by Sumitomo Dainippon Pharma Co., Ltd

    Find Ranirestat bulk offered by Sumitomo Dainippon Pharma Co., Ltd

    Find Rimacalib bulk offered by Sumitomo Dainippon Pharma Co., Ltd

    Find Sm-216601 bulk offered by Sumitomo Dainippon Pharma Co., Ltd

    Find Smp 797 bulk offered by Sumitomo Dainippon Pharma Co., Ltd

    Find Sparfloxacin bulk offered by Sumitomo Dainippon Pharma Co., Ltd

    Find SMP-028 bulk offered by Sumitomo Dainippon Pharma Co., Ltd

    Find SMP-986 bulk offered by Sumitomo Dainippon Pharma Co., Ltd

    Find Blonanserin bulk offered by Sumitomo Dainippon Pharma Co., Ltd

    Find Mosapride Citrate bulk offered by Sumitomo Dainippon Pharma Co., Ltd

    Find Sodium Hyaluronate bulk offered by Sumitomo Dainippon Pharma Co., Ltd

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search